Landon Myer

Landon Myer

Landon Myer

Adjunct Associate Professor
Epidemiology

Office/Address:

Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town
University of Cape Town, Anzio Road, Observatory South Africa 7925

Phone:
+27 21-406-6661
Fax:
+27 21-406-676
Website address: Email: Twitter:

Biography

Landon Myer is the Director and Head of the School of Public Health & Family Medicine at the University of Cape Town (UCT) in South Africa. Within the School, he is Professor and Head of the Division of Epidemiology & Biostatistics, teaches epidemiologic methods and is academic convenor of the Masters in Public Health programme. His background is in social anthropology, clinical medicine and epidemiology. His work centres around women's, maternal and child health in the context of the HIV epidemic, and includes behavioural, clinical and health systems research. He has a particular focus on the health of HIV-infected women during pregnancy and postpartum as well as the health and development of their children

Education

BA, 1996, Brown University
PhD, 2005, Columbia University
M Phil, 2002, Columbia University
MA, 1999, University of Cape Town
MBBCH, 2008, University of Cape Town
BA, Brown University

Editorial Boards

International Journal of Epidemiology

AIDS Patient Care & STDs

Other Affiliations

International Epidemiological Association

Royal Statistical Society

South African Medical Association

Southern African HIV Clinicians Society

Public Health Association of South Africa

Honors & Awards

British Association Award, Southern African Association for the Advancement of Science
International Leadership Award, Elizabeth Glaser Pediatric AIDS Foundation
African Union Scientist Award, TWAS / Academy of Science of South Africa

Select Global Activities

Maternal & Child Health - Antiretroviral Therapy (MCHART) study, South Africa: This implementation science study examines critical clinical and health services issues involved in the initiation of antiretroviral therapy in HIV-infected pregnant women as well as the long-term follow-up of postpartum women on ART. Nested substudies focus on alternative strategies for postpartum follow-up of women on ART (the PACER study), as well as comparisons of the health of HIV-exposed, uninfected children to of HIV-unexposed controls (HU2 study).

Drakenstein Child Health Study: The Drakenstein Child Health Study (DCHS) is a birth cohort study following ~1,000 mother child pairs to investigate the epidemiology, aetiology and risk factors for childhood lower respiratory illness and subsequent impact on child health, including the development of chronic respiratory disease. The study aims to investigate the role and interaction of potential risk factors covering 7 areas (environmental, infectious, nutritional, genetic, psychosocial, maternal and immunological risk factors) that may impact on child health. This approach will provide an innovative, longitudinal assessment of a range of clinical, molecular, environmental and socioeconomic variables impacting on childhood respiratory illness and the evolution of chronic disease in a middle-income country setting.

Cape Town Adolescent Antiretroviral Cohort (CTAAC), South Africa: The health of adolescents perinatally-infected with HIV is shaped by an interplay of factors evolving over the course of physical and psychosocial development. The overall goal of Cape Town Adolescent Antiretroviral Cohort (CTAAC) is to investigate markers of chronic disease processes and progression in perinatally HIV-infected SA adolescents focusing in five key areas (general adolescent development; neurocognitive function; pulmonary disease; cardiovascular function; and musculoskeletal disease).

Select Publications

Myer L, Phillips TK. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S115-S122.

Myer, L., Wilkinson, D., Lombard, C., Zuma, K., Rotchford, K., Abdool Karim, S.S. Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial. Sexually Transmitted Infections 79 208-213 2003

Stein, Z.A., Myer, L., Susser, M. The design of prophylactic trials for HIV: The Case of Microbicides. Epidemiology 14 80-3 2003

Myer, L., Denny, L., Telerant, R., De Souza, M., Wright, T.C., Kuhn, L. Bacterial vaginosis and susceptibility to HIV infection among South African women: a nested case-control study. Journal of Infectious Diseases 192 1372-80 2005

Lawn, S.D., Myer, L., Orrell, C., Bekker, L.G., Wood, R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19 2141-2148 2005

Myer L, Essajee S, Broyles LN, Watts DH, Lesosky M, El-Sadr WM, Abrams EJ. Pregnant and breastfeeding women: A priority population for HIV viral load monitoring. PLoS Med. 2017 Aug 15;14(8):e1002375.

Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, Maskew M, Prozesky H, Wood R, Johnson LF, Egger M, Boulle A, Myer L; International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 2012;9(9):e1001304.

Grimsrud AT, Cornell M, Egger M, Boulle A, Myer L. Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU. J Clin Epidemiol. 2013 Sep;66(9):1006-13.

Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy J, Wood R, Prozesky H, Mohapi L, Graber C, Egger M, Boulle A, Myer L; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24 2263-70 2010

Myer, L., Denny, L., Wright, T.C., Kuhn, L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. International Journal of Epidemiology 36 166-74 2007

Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010 Feb 9;7(2):e1000229.

Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010 Feb 9;7(2):e1000229.

Back to Top